Immune Thrombocytopenia (ITP) Immune-Genetic Assessment (UNIT)
IMMUNE-GENETIC ASSESSMENT OF PRIMARY ITP IN ADULT
Sponsor: Azienda Sanitaria-Universitaria Integrata di Udine
A observational or N/A phase clinical study on Thrombocytopenia, this trial is ongoing. The trial is conducted by Azienda Sanitaria-Universitaria Integrata di Udine and has accumulated 8 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — May 2017 [monthly]
Unknown Status NA
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Sanitaria-Universitaria Integrata di Udine
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bologna, Italy , Cagliari, Italy , Florence, Italy , Milan, Italy , Novara, Italy , Padua, Italy , Ravenna, Italy , Roma, Italy , Treviso, Italy , Udine, Italy and 1 more location